Pharmacists must take time to understand why patients are not adherent to HIV pre-exposure prophylaxis (PrEP) and what barriers exist, said Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDES, assistant professor at the University of South Florida Taneja College of Pharmacy.
Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDES, assistant professor at the University of South Florida Taneja College of Pharmacy, talks about the pharmacist's role in educating patients on HIV risk and promoting pre-exposure prophylaxis (PrEP) adherence.
Transcript
What is the pharmacist’s role in making PrEP therapies available to people at high risk of contracting HIV?
The biggest role that pharmacists can have is educating patients about their risk level. I think right now there's a big community-wide knowledge gap about what the risk factors are and who would benefit from PrEP, so as pharmacists, we can be patient facing, we can do a lot of education within the community. We're also seeing a lot of states are passing collaborative practice agreements and PrEP protocols for pharmacists to be able to prescribe PrEP and continue therapy for patients. So I think really expanding access where possible.
What is their role in promoting adherence?
Very similar. As pharmacists, we're able to see what prescriptions patients are filling, how often they're coming in to get their refills. So, [we're] really able to help keep patients on track with their medications, identifying any gaps. We can reach out and understand where the nonadherence comes from. I think that's a big concern. We learn that adherence is an issue, and a lot of times we'll just label the patient is either nonadherent or they're not taking their medicine. We need to take the time to understand why they're not taking their medications and what barriers there are. I think pharmacists are really instrumental in that role.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More